Sign Out
Safe use of the drug during pregnancy has not been established. It crosses the placenta barrier; therefore it is recommended not to use in pregnancy, except only when the potentials benefit justifies the possible risks to the fetus. Avoid NSAIDs including Meloxicam in the last trimester (30 weeks and above) of pregnancy as premature closure of ductus arteriosus, affecting the lung and heart function of the fetus, may occur.
The drug is distributed in the milk of lactating rats. There are no studies in human; therefore it is not recommended to use in nursing mothers. A decision should be made whether to discontinue nursing or the drug.
Continue with Google